Evidence map›Paper›PMID 39375549›Full record

ArticleNature immunology2024

Histone lactylation drives CD8

Deblina Raychaudhuri, Pratishtha Singh, Bidisha Chakraborty, Mercedes Hennessey, Aminah J Tannir, Shrinidhi Byregowda, Seanu Meena Natarajan, Abel Trujillo-Ocampo, Jin Seon Im, Sangeeta Goswami

Abstract read
In one paragraph

Article in Nature immunology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 135 papers.

0numbers the graph read from it
0cells of the map it votes in
135citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

135 citing papers in PubMed.

  1. Trial
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Review
  10. Review
  11. Epigenetic insights and innovations for overcoming barriers in CAR-T cell therapy for cancer.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2026
    Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. AARS1-Mediated RUNX3 K193 Lactylation Enhances the Activation and Cytotoxicity of CD8Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  17. Review
  18. Article
  19. Unveiling Lactylation: A Novel Frontier in Cancer Stemness and Therapy.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Review
  20. Review

75 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Deblina Raychaudhuri *Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Pratishtha Singh *Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.ORCID http://orcid.org/0000-0002-9197-7241
Bidisha ChakrabortyDepartment of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Mercedes HennesseyDepartment of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Aminah J TannirDepartment of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Shrinidhi ByregowdaDepartment of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Seanu Meena NatarajanDepartment of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Abel Trujillo-OcampoDepartment of Hematopoietic Biology and Malignancy, Division of Cancer Medicine, MD Anderson Cancer Center, Houston, TX, USA.
Jin Seon ImDepartment of Hematopoietic Biology and Malignancy, Division of Cancer Medicine, MD Anderson Cancer Center, Houston, TX, USA.
Sangeeta GoswamiDepartment of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. sgoswami@mdanderson.org.ORCID http://orcid.org/0000-0001-9201-4503

Funding

Targeting epigenetic machinery to overcome myeloid cell-mediated resistance to anti-PD-1 therapy in GBMR37CA279192 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Sangeeta Goswami · 2023 to 2026
$1.9M
NCI NIH HHS R37 CA279192
6 · The paper itself

Abstract

The activation and functional differentiation of CD8

Indexed as

CD8-Positive T-LymphocytesHistonesLymphocyte ActivationProtein Processing, Post-TranslationalAnimalsCell DifferentiationEpigenesis, GeneticHumansMiceMice, Inbred C57BLHistones

Identifiers

PMID39375549
PMCPMC13211864

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.